Related Experiment Video

Updated: Sep 27, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence

Ewald Witteveen1, Erik J C van Ameijden

  • 1Cluster Infectious Diseases, Municipal Health Service, Nieuwe Achtergracht 100, 1018 WT Amsterdam, The Netherlands. ewitteveen@gggd.amsterdam.nl

Substance Use & Misuse
|January 4, 2003
PubMed

Insights

Many hard drug users struggle with adherence to highly active antiretroviral therapy (HAART). Understanding factors affecting HAART compliance is crucial for improving HIV treatment effectiveness in this population.

Area of Science:

  • Medical Science
  • Public Health
  • Infectious Diseases

Background:

  • Highly active antiretroviral therapy (HAART) effectively suppresses HIV replication but requires strict adherence.
  • HIV-positive individuals, particularly hard drug users, face challenges in maintaining therapy compliance.
  • Poor adherence to HAART jeopardizes treatment effectiveness and can lead to drug resistance.

Purpose of the Study:

  • To investigate adherence to HAART among hard drug users in Amsterdam.
  • To identify factors that impede or facilitate HAART adherence in this population.
  • To inform the development of strategies to improve HAART effectiveness.

Main Methods:

  • Qualitative study utilizing in-depth interviews.
  • Conducted with 27 hard drug users in Amsterdam.
  • Explored experiences and challenges related to HAART adherence.

Main Results:

  • Nearly half of the interviewed hard drug users reported non-adherence to HAART.
  • Multiple determinants of adherence were identified, spanning medication, individual, and environmental factors.
  • Many identified determinants are potentially modifiable.

Conclusions:

  • Adherence to HAART is a significant issue for hard drug users.
  • Understanding multifaceted determinants is key to improving adherence.
  • Interventions targeting modifiable factors can enhance HAART effectiveness in this vulnerable group.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...